This is a Validated Antibody Database (VAD) review about dog AIFM1, based on 7 published articles (read how Labome selects the articles), using AIFM1 antibody in all methods. It is aimed to help Labome visitors find the most suited AIFM1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
AIFM1 synonym: apoptosis-inducing factor 1, mitochondrial
Cell Signaling Technology
rabbit monoclonal (D39D2) |
| Cell Signaling Technology AIFM1 antibody (Cell Signaling, 5318) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4b). Nucleic Acids Res (2019) ncbi |
rabbit monoclonal (D39D2) |
| Cell Signaling Technology AIFM1 antibody (Cell Signaling, 5318) was used in western blot on mouse samples at 1:1000 (fig 7e). Diabetologia (2019) ncbi |
rabbit monoclonal (D39D2) |
| Cell Signaling Technology AIFM1 antibody (Cell Signaling, 5318) was used in western blot on human samples (fig 1d). Mol Cell Biochem (2019) ncbi |
rabbit monoclonal (D39D2) |
| Cell Signaling Technology AIFM1 antibody (CST, 5318S) was used in immunohistochemistry on human samples at 1:1500 (fig s2b). Sci Adv (2018) ncbi |
rabbit monoclonal (D39D2) |
| In order to learn about protection against acetaminophen hepatotoxicity by mitochondria-targeted antioxidant Mito-Tempo, Cell Signaling Technology AIFM1 antibody (Cell Signaling Technology, 5318) was used in western blot on mouse samples at 1:1000 (fig 5). Arch Toxicol (2017) ncbi |
rabbit monoclonal (D39D2) |
| Cell Signaling Technology AIFM1 antibody (Cell Signaling Technology, 5318) was used in western blot on mouse samples at 1:1000 (fig 3). PLoS ONE (2016) ncbi |
rabbit monoclonal (D39D2) |
| Cell Signaling Technology AIFM1 antibody (Cell Signaling, D39D2) was used in immunocytochemistry on human samples at 1:400 and in western blot on human samples at 1:1000. Mol Oncol (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments